Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockman6767on Jul 09, 2021 4:36pm
145 Views
Post# 33522664

What exactly is in PBP and what is in PBT aside from the PVR

What exactly is in PBP and what is in PBT aside from the PVRWhat exactly is in PBP and what is in PBT aside from the PVR?

I also imagine that one of the main conditions for the "second closing" is likely the sale of the PVT and giving LMNL its share of the PVR proceeds. Anyone have any idea what the other conditions of the sale are and why they are so mysterious? Do PBP and PBT represent 100% of the protein business that PLI had developed, or is there ant part of the protein business not included in this sale to Kedrion after the "second closing"?
<< Previous
Bullboard Posts
Next >>